---
title: "Intraday News - Lipeng (1447) plummets -3.39% to report 5.47 yuan, with a trading volume of 1,627 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286837026.md"
description: "Lih Peng (1447-TW) stock price plummeted 3.39%, closing at NT$ 5.47, with a trading volume of 1,627 shares, and a decline of 5.03% today. Over the past 5 days, the stock price has risen by 16.13%, outperforming the market. The net buying and selling by the three major institutional investors totaled -1,472 shares, with foreign investors having a net of -1,463 shares"
datetime: "2026-05-19T01:22:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286837026.md)
  - [en](https://longbridge.com/en/news/286837026.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286837026.md)
---

# Intraday News - Lipeng (1447) plummets -3.39% to report 5.47 yuan, with a trading volume of 1,627 shares

Lih Peng ( 1447-TW) has dropped 3.39% in the last 5 minutes, reporting at NT$5.47 at 09:22 on the 19th, with a trading volume of 1,627 shares, and a decline of 5.03% today. (Note: The price change rate refers to the 5-minute price fluctuation)

Lih Peng ( 1447-TW) has increased by 16.13% in the last 5 days, belonging to the textile fiber industry, while related textile fibers have decreased by 2.65%. The weighted index of the centralized market Weighted Index has dropped by 2.15%, and the stock price performance has outperformed the market.

_Near 5-day chip_

-   Total net buy/sell by the three major institutions: -1,472 shares
-   Foreign investment net buy/sell: -1,463 shares
-   Investment trust net buy/sell: 0 shares
-   Proprietary traders net buy/sell: -9 shares
-   Margin increase/decrease: -148 shares
-   Short selling increase/decrease: 0 shares

### Related Stocks

- [01447.HK](https://longbridge.com/en/quote/01447.HK.md)

## Related News & Research

- [Automation and market shifts put 10 trade jobs at risk](https://longbridge.com/en/news/290330087.md)
- [15:05 ETGlobal Cellulose Fibers Announces CEO Transition](https://longbridge.com/en/news/290600601.md)
- [Agomab wins FDA alignment for NOV-ERA Phase 2b design in fibrostenosing Crohn’s disease](https://longbridge.com/en/news/290603476.md)
- [Jinhui Holdings Delays Circular for Major Two-Vessel Acquisition](https://longbridge.com/en/news/290775957.md)
- [Bergen Carbon Solutions releases June 2026 shareholder letter](https://longbridge.com/en/news/290777123.md)